<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>AstraZeneca Pharmaceuticals LP et al v. Hetero USA Inc. :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2026cv01437/95373</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2026cv01437/95373/feed" rel="self" type="application/rss+xml" />
        <pubDate>Sat, 14 Nov 2026 15:40:30 -0800</pubDate>
        <lastBuildDate>Sat, 14 Nov 2026 15:40:30 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>AstraZeneca Pharmaceuticals LP et al v. Hetero USA Inc. - Docket Entries - Showing 1 through 10</description>
                                    <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Hetero USA Inc. on 11/9/2026. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762372</guid>
                <pubDate>
            Mon, 09 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for MSD International Business GmbH filed by MSD International Business GmbH. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762373</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for KuDOS Pharmaceuticals Limited filed by KuDOS Pharmaceuticals Limited. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762374</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Array BioPharma, Inc. filed by Array BioPharma, Inc.. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762375</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Alexion Pharma International Operations Limited filed by Alexion Pharma International Operations Limited. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762376</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762377</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,813,246; 12,220,403; 12,318,367; 12,364,684. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762378</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 9/25/2026. Date of Expiration of Patent: 3/26/2029. Thirty Month Stay Deadline: No earlier than 3/25/2029. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762379</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762380</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT for Patent Infringement against Hetero USA Inc. (Filing fee $ 405, receipt number ADEDC-5108586) - filed by AstraZeneca Pharmaceuticals LP, Alexion Pharma International Operations Limited, Array BioPharma, Inc., KuDOS Pharmaceuticals Limited, MSD International Business GmbH. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_38762381</guid>
                <pubDate>
            Fri, 06 Nov 2026 00:00:00 -0800
        </pubDate>
    </item>
                </channel>
</rss>
